Primary Site >> Stomach Cancer
Gene >> RPL22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer]. PMID: 2596854 Ref: Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. PMID: 2769330 Ref: [The effect of EAP (etoposide, adriamycin, cis-platinum) on patients with advanced gastric cancer: the role of EAP as neoadjuvant chemotherapy and histopathological study on its effect]. PMID: 2782922 |
Ref: [Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer]. PMID: 2241183 Ref: EAP in advanced gastric cancer. PMID: 2332776 Ref: [Effect of high dose etoposide, adriamycin, cisplatin (EAP) therapy with autologous bone marrow transplantation in gastric cancer]. PMID: 2334173 |
Ref: Perspectives in chemotherapy of advanced gastric cancer. PMID: 1835661 Ref: Combination of etoposide, adriamycin and cisplatin (EAP) in gastric cancer: association with severe toxicity. PMID: 1868028 Ref: Combination of etoposide, adriamycin and cisplatin (EAP) in gastric cancer: association with severe toxicity. PMID: 1868029 Ref: The effectiveness of a combination of etoposide/adriamycin/cisplatin (EAP) against inoperable gastric cancer--report of a histologically proven case. PMID: 1960901 Ref: Current strategies in the management of locoregional and metastatic gastric carcinoma. PMID: 1984825 Ref: [Evaluation of EAP (etoposide, adriamycin, cisplatin) for highly advanced gastric cancer in a neoadjuvant setting]. PMID: 2012406 Ref: An early phase II study of 5-fluorouracil combined with cisplatinum as a second line chemotherapy against metastatic gastric cancer. PMID: 2067126 |
Ref: [Epidemiology and treatment of stomach cancer: news in 1992]. PMID: 1303492 Ref: [A case of gastric carcinoma with peritonitis carcinomatosa responding remarkably to etoposide, adriamycin and cisplatin (EAP) therapy]. PMID: 1463349 Ref: FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer. PMID: 1548519 |
Ref: EAP in advanced gastric cancer. PMID: 8518041 |
Ref: [Recurrence and survival rate of advanced gastric cancer after preoperative EAP-II intra-arterial infusion therapy]. PMID: 7944452 Ref: Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer. PMID: 7967107 Ref: Etoposide, doxorubicin and cisplatin (EAP regimen) in advanced gastric cancer. PMID: 7983505 Ref: [A case of curatively operated gastric cancer with peritonitis carcinomatosa treated by intraperitoneal administration of CDDP.Etoposide and EAP therapy]. PMID: 7993123 Ref: Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule. PMID: 8045920 Ref: Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group. PMID: 8080673 Ref: Treatment of gastric adenocarcinoma with the combination of etoposide, adriamycin and cisplatin (EAP): comparison between two schedules. PMID: 8265093 Ref: [Successful treatment of two patients with advanced gastric cancer by neoadjuvant chemotherapy with EAP regimen]. PMID: 8311499 |
Ref: The treatment of advanced gastric cancer. PMID: 8658224 |
Ref: Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer. PMID: 9142190 |
Ref: [The German EORTC Study of neoadjuvant therapy of stomach carcinoma]. PMID: 9931709 |
Ref: [A gastric cancer patient with marked para-aortic lymph node metastasis surviving more than 10 years after aggressive operation and repeated EAP chemotherapy]. PMID: 11915738 Ref: Etoposide, doxorubicin and cisplatin alternating with 5-fluorouracil, doxorubicin and high-dose methotrexate in patients with advanced adenocarcinoma of the stomach or the gastroesophageal junction. PMID: 12583555 |
Ref: A multimodal treatment approach including high-dose chemotherapy in very advanced gastric cancer: evidence for control of metastatic disease. PMID: 13130313 |
Ref: Mobilization of peripheral blood stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in advanced gastric cancer. PMID: 15254697 |
Ref: Bimonthly 24 h infusion of high-dose 5-fluorouracil vs EAP regimen in patients with advanced gastric cancer. A randomized phase II study. PMID: 17972024 |
Ref: Growth-promoting properties of Epstein-Barr virus EBER-1 RNA correlate with ribosomal protein L22 binding. PMID: 19640998 |
Ref: Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial. PMID: 20215786 |
Ref: Postoperative chemotherapy in gastric cancer, consisting of etoposide, doxorubicin and cisplatin, followed by radiotherapy with concomitant cisplatin: A feasibility study. PMID: 22783410 Ref: Whole-genome reconstruction and mutational signatures in gastric cancer. PMID: 23237666 |
Ref: Clonal Structures of Regionally Synchronous Gastric Adenomas and Carcinomas. PMID: 29945994 |